key: cord-0073106-ndjj63ow authors: Wilmore, Joel R.; Gaudette, Brian T.; Gómez Atria, Daniela; Rosenthal, Rebecca L.; Reiser, Sarah Kim; Meng, Wenzhao; Rosenfeld, Aaron M.; Luning Prak, Eline T.; Allman, David title: IgA Plasma Cells Are Long-Lived Residents of Gut and Bone Marrow That Express Isotype- and Tissue-Specific Gene Expression Patterns date: 2021-12-24 journal: Front Immunol DOI: 10.3389/fimmu.2021.791095 sha: 9653e7be1e120a77f7fc8e25a5a50ff9d951c10f doc_id: 73106 cord_uid: ndjj63ow Antibody secreting plasma cells are made in response to a variety of pathogenic and commensal microbes. While all plasma cells express a core gene transcription program that allows them to secrete large quantities of immunoglobulin, unique transcriptional profiles are linked to plasma cells expressing different antibody isotypes. IgA expressing plasma cells are generally thought of as short-lived in mucosal tissues and they have been understudied in systemic sites like the bone marrow. We find that IgA(+) plasma cells in both the small intestine lamina propria and the bone marrow are long-lived and transcriptionally related compared to IgG and IgM expressing bone marrow plasma cells. IgA(+) plasma cells show signs of shared clonality between the gut and bone marrow, but they do not recirculate at a significant rate and are found within bone marrow plasma cells niches. These data suggest that systemic and mucosal IgA(+) plasma cells are from a common source, but they do not migrate between tissues. However, comparison of the plasma cells from the small intestine lamina propria to the bone marrow demonstrate a tissue specific gene transcription program. Understanding how these tissue specific gene networks are regulated in plasma cells could lead to increased understanding of the induction of mucosal versus systemic antibody responses and improve vaccine design. Newly generated plasma cells either die within days, or take up residency in tissues such as the bone marrow (BM) or the lamina propria of the small intestine (siLP) where they can persist indefinitely as high output antibody secreting cells (1) (2) (3) (4) . Whereas the induction and maintenance of IgGsecreting cells in BM has been studied extensively (5) , much less is known about the factors that influence the induction and maintenance of IgA-secreting plasma cells in the gut or other tissues. IgA is the dominant antibody class produced throughout the body and the continuous secretion of IgA along the intestinal epithelium is critical for preventing intestinal disequilibrium and shaping communities of commensal microbes (6) . Furthermore, recent data reveal that commensal bacteria in the gut and potentially elsewhere can induce the production of serum IgA and IgG antibodies that form a protective humoral barrier against systemic infection (7, 8) . Consistent with this function, many microbiota-induced IgA-secreting plasma cells can be identified in non-mucosal sites such as the BM (7) and spleen (9) . It is not understood how plasma cells that arise in mucosal tissues home to the BM, or whether such cells persist for extended periods as marrow-resident cells. It is widely accepted that the BM contains unique regulatory microenvironments needed for long-term plasma cell survival. Consistent with this view, BM plasma cells localize preferentially in perivascular niches orchestrated by CXCL12-positive stromal cells where they interact with several diverse cell types that may contribute to plasma cell survival (5) . However, unlike IgM-and IgG-secreting plasma cells in the spleen, lymph node, and BM, intestinal IgA + plasma cells home to and remain in mucosal tissues by employing the chemokine receptors CCR9, CCR10, and the integrin a 4 b 7 (10, 11) . Whether these processes are used by IgA-secreting plasma cells in BM is uncertain. It has also been proposed that plasma cells have function beyond antibody generation (12) . Plasma cells in the central nervous system and other sites produce immunosuppressive cytokines such as IL-10 (13) , and many IgA-secreting cells in the gut produce the antimicrobial mediators tumor-necrosis factor-a and inducible nitric oxide synthase (14) . Thus, subpopulations of plasma cells may activate unique gene expression modules needed for additional immunomodulatory functions. Consistent with this idea, it was shown recently that plasma cells expressing different immunoglobulin (Ig) heavy chain (IgH) isotypes have distinct gene expression profiles (15) . However, it is unknown whether IgA-secreting cells in the BM and siLP maintain distinct, tissue-associated transcriptional profiles, or are dictated by IgH isotype alone. Furthermore, it is becoming clear that mature IgM-and IgAsecreting plasma cells often retain functional Ig surface receptors (16) , raising additional questions about the impact of particular IgH isotypes on plasma cell gene expression and function. Based on these considerations we sought to ask: 1) Are BM IgA-secreting plasma cells long-lived BM-resident cells? If so, do BM IgA-secreting plasma cells localize to specialized microenvironments within the BM parenchyma that overlap with those employed by IgG-secreting cells? 2) Does movement of IgA + plasma cells to the BM coincide with the expression of unique gene expression patterns, or do BM IgA + plasma cells share gut-associated gene expression patterns with IgA + plasma cells in the siLP? And 3) To what extent does IgAcorrelated gene expression require surface IgA expression? Our results demonstrate that BM IgA + plasma cells are long-lived and readily integrate into canonical perivascular plasma cell niches where they express a unique IgA-correlated gene expression program mirroring their counterparts in the gut. Furthermore, we show that the gut environment also imparts tissue-specific gene expression on siLP plasma cells, regardless of surface Ig isotype. B6.Blimp1 +/GFP (17) , B6.IgA -/- (18) , and C57BL/6 (B6) mice were bred and maintained at the University of Pennsylvania under specific pathogen free conditions. All experiments were performed in accordance with the Office of Regulatory Affairs Institutional Animal Care and Use Committee. Cells were stained for flow cytometric analysis as previously described (19) . Exclusion of dead cells was performed using Zombie Aqua Fixable Viability kit (BioLegend) according to the manufacturer's instructions. The following antibodies were used for staining and analysis: PE-anti-CD138 (BD; 281-2), -CxCR4 (eBioscience (eBio); 2B11), -IgM (BD; R26-46), PerCP-eFluor710-anti-IgM (eBio; II/41), -CCR9 (eBio; eBioCW-1.2), PE-Cy7-anti-CD4 (eBio; GK1.5), -CD8a (eBio; 53-6.7), -Gr1 (eBio; RB6-8C5), -F4/80 (eBio; BM8), -TER-119 (BioLegend), APC-anti-B220 (Tonbo; RA3-6B2), APC-Cy7-anti-IgD (BioLegend; 11-26c.2a), Biotin-anti-IgA (BioLegend; RMA-1), -a 4 b 7 (BioLegend; DATK32), BrilliantViolet605-anti-Thy1.2 (BioLegend; 53-2.1), AF700 anti-CD45.2 (BioLegend; 104), and BV785-anti-CD19 (BioLegend; 6D5). To detect biotin-conjugated antibodies we used streptavidin-BV421 (BioLegend). Labeling with 5-bromo-2'-deoxyuridine was performed by adding 0.6mg/ml BrdU and 1mg/ml sucrose into the drinking water. Cells were then stained for flow cytometry with the methods described above. Following the last wash step the cells were fixed and permeabilized using Fixation Medium A and Permeabilization Medium B (ThermoFisher). Cells were then treated with a DNase solution containing 0.3M NaCl, 4mM MgCl 2 , and 0.25mg/ml DNaseI (Sigma) for 40 minutes, and then washed and stained with APC-anti-BrdU (eBio; BU20A). Data was collected using an LSRII Fortessa (BD) and cell sorting was performed on an AriaII Cell Sorter (BD). All cell sorting experiments were performed with double sorting, bone marrow plasma cells were first sorted on plasma cell identity (Live, Dump -(CD4, CD8, F4/80, and Ter119), IgD -, CD138 + , Blimp GFP+ ) then sorted again for plasma cell identity with the addition of antibody isotype (IgA + , IgM + , or IgA -IgM -) and siLP plasma cells were sorted without CD138 and on IgA + for both sorts (IgA -/samples were double sorted on Blimp GFP+ without the use of IgA). We followed the tissue clearing and staining protocol reported by Acar et al. (20) . Bones from B6.Blimp1 +/GFP reporter mice were fixed in 4% PFA for 6 h, immersed in 30% sucrose O/N, cryopreserved in OCT (Fisher Scientific) and longitudinally bisected on a cryostat. For staining, half bones were rinsed in PBS and blocked overnight in staining solution (10% DMSO, 0.5% IgePal630 and 5% donkey serum) with TrueStainFcX FcR block (Biolegend). The same staining solution was used with labeled antibodies against GFP (polyclonal rabbit anti-mouse, Cat#A21311, Life Technologies), IgA (clone RMA-1, Biolegend), IgM (BV421 clone RMM-1, Biolegend), and Laminin 1 + 2 (polyclonal rabbit anti-mouse, Cat# ab7463, Abcam) for 3 days, followed by PBS wash for 1 day. Anti-laminin and anti-IgA antibodies were conjugated to CF568 and CF647 respectively using a Biotium Mix-n-Stain antibody labeling kit according to manufacturer's protocols. To clear the tissue, bones were dehydrated in increasing ethanol concentration and then incubated overnight in BABB solution (1:2, benzyl alcohol: benzyl benzoate). Images were obtained on a Zeiss LSM710 confocal microscope and analyzed using Imaris 8.2 (Bitplane) software. C57BL/6 (CD45.2) and B6.CD45.1 adult female mice were connected by parabiosis as previously described (21) . In brief, mice were anesthetized with isoflurane and/or ketamine (100-200 mg/kg) and xylazine (5-16 mg/kg). A skin incision was made from the olecranon to the knee of each of the mice to be joined. The elbows and knees of the two paired mice were then tied together with surgical suture, followed by connecting of the skin with surgical sutures and staples. For pain control, mice were given buprenorphine (0.1 mg/kg) and ketoprofen (5 mg/kg) for up to 3 days after surgery. Mice were provided with sulfamexathole (400 mg/L) and trimethoprim (80 mg/L) antibiotics in their drinking water to prevent infection. Mice were monitored for signs of pain, infection, or damage to sutures. Blood was periodically drawn to check for anastomoses, which appeared complete by day 17 at which time mice were euthanized and the BM and siLP were harvested. ELISpot assays were performed according to standard protocols. Briefly, ELISpot plates (EMD Millipore MSIPS4W10) were coated with anti-mouse Ig(H+L) (Southern Biotech 1010-01) in a sodium carbonate/bicarbonate solution pH 9.6 and detection was performed with anti-IgM, IgA, IgG, k, and l antibodies conjugated to biotin (Southern Biotech). Biotinylated antibodies were revealed with streptavidin-alkaline phosphatase (Sigma E2636) and developed with BCIP/NBT (Sigma B1911). ELISpot plates were imaged and spots were counted using a CTL Immunospot Analyzer (Cellular Technologies Limited). Amplicons encoding IgA from siLP and BM plasma cells were generated using the semi-nested PCR approach and oligonucleotides reported by Lindner et al. (22) . However oligonucleotides were modified to include adaptor sequences for the Illumina NexteraXT kit and are as follows Raw sequencing data in FASTQ format were quality controlled using pRESTO version 0.5.10 (23) as described in (24) . Briefly, paired reads were aligned, low quality reads were removed (those with an average Phred quality score of < 30), individual nucleotides with a quality score < 30 were masked with Ns, and sequences with more than 10 Ns were removed. The remaining sequences were aligned and annotated with V & J genes using IgBLAST version 1.16.0 (25) . Following this, sequences were imported into ImmuneDB (26) version 0.29.10 for clonal inference and downstream analysis. Sequences sharing the same Vgene, J-gene, and CDR3 length were hierarchically clustered and groups of sequences sharing at least 85% amino-acid homology in the CDR3 region were grouped into clones. The framework 1 region of VH genes was trimmed off to remove the primer binding region to ensure the accuracy of SHM calculation. Cell populations were sorted directly into Trizol with 0.5% 2-ME and held at -80°C until RNA preparation. RNA was prepared using Trizol RNA-extraction according to the manufacturer's protocol (Thermo-Fisher Scientific). RNA was co-precipitated using glycogen as a carrier. RNA was quantified using Qubit RNA high sensitivity fluorometric assay. cDNA was prepared using Takara Clontech SMART-Seq ® HT Kit according to protocol using 500-1000 ng RNA as input. cDNA was quantified and qualified using the HS-DNA assay on an Agilent 4200 Tapestation. RNA-seq libraries were constructed using the Illumina Nextera XT kit with 150 ng cDNA input. Libraries were quality controlled and quantified by Tapestation and pooled at equal molar ratio prior to sequencing on Illumina Nextseq500 (75bp SE v2) machines. Transcript abundance was computed by pseudoalignment with Kallisto (27) . Transcript per million (TPM) values were then normalized and fitted to a linear model by empirical Bayes method with the Voom and Limma R packages (28, 29) . Differential gene expression was defined as a Benjamini-Hochberg corrected p-value of < 0.05 and fold change > 2, unless otherwise noted. GO analysis was performed using the DAVID Bioinformatics Resources 6.8, NIAID, NIH as well as ClueGO and Cytoscape. The enrichment score calculation from Bonferroni step-down adjusted P values < 0.05 was used to define enriched terms and clusters of terms, choosing the term with highest number of represented genes as founder term for each cluster. Nondescriptive or overly general terms were disregarded in favor of the term with the next highest number of genes represented (30) (31) (32) . One proposed model of antibody mediated homeostasis in the gut posits that IgA + plasma cell responses in the siLP are designed to allow for the adaptation to changing microbial communities in the gut over time, resulting in displacement of long-lived plasma cells with newcomers (33) . Recent work from our group and others describing large numbers of BM IgA + plasma cells under certain conditions led us to ask if the BM plasma cell niche was capable of inducing long-term survival of IgA + plasma cells (7, 34) . To characterize plasma cells longevity, we developed a flow cytometric approach to distinguish BM plasma cells secreting each heavy chain isotype. To ensure that our analyses focused on bona fide plasma cells we employed B6.Blimp1 +/GFP adult mice born and raised in our colony, focusing on viable GFP/Blimp1 + CD138 + BM cells defined further by surface expression of IgM or IgA. Notably, although activated B cells are thought to downregulate surface Ig expression during plasma cell differentiation, consistent with recent studies (16, 35) we readily identified surface IgM + and IgA + cells among intact Blimp1 + CD138 + cells ( Figure S1A ). By contrast, we were unable to discern surface IgG expression among any GFP/Blimp1 + CD138 + BM cells. To confirm that each population was highly enriched for cells secreting the expected Ig heavy chain isotype, we sorted cells from each GFP/Blimp1 + CD138 + fraction into ELISpot plates coated with antibodies specific for total Ig(H+L), and detected with isotype-specific antibodies. As expected, IgA-secreting cells were readily and exclusively detected among the IgA + fraction, while the IgM + fraction was enriched only for IgM-secreting cells, and the IgA -IgMfraction contained only IgG-secreting cells (Figures S1B, C). Previously we described surface B220 expression as a defining feature of short-lived plasma cells in the spleen and BM (36) . Therefore, we sought to define the phenotype of each BM plasma cell isotype based on B220 expression. Staining revealed that the majority of BM IgA + plasma cells were B220 -, consistent with a long-lived phenotype. In contrast, the majority of IgM + and IgM -IgAplasma cells were B220 + (Figures 1A, B) . Interestingly, the siLP IgA + plasma cell pool consists almost entirely of IgA + B220plasma cells, indicative of a long-lived phenotype. These findings contrast with reports of siLP plasma cell pools being dominated by shortlived cells (33, 37) . To confirm these results, we utilized continuous in vivo BrdU labeling to assess population turnover kinetics. As shown, BM and siLP IgA + B220plasma cells incorporated relatively little BrdU over 17 days compared to B220 + BM plasma cells, but a similar amount to IgA -B220 -BM plasma cells. ( Figure 1C ). Our data suggest that mouse BM and siLP can harbor substantial numbers of long-lived IgA-secreting plasma cells. We next sought to confirm that IgA-secreting BM cells are not a circulating population, but located within the BM parenchyma long-lived plasma cell niche. To address this, we took multiple approaches, beginning with performing parabiosis using mice distinguished by congenic markers. The mice were joined for 17 days, then flow cytometric analysis of BM and siLP plasma cells was performed to determine the percentage of donor cells that contributed to the standing plasma cell pool. As expected, we found that naïve IgD + B cells were nearly 50% donor-derived in both the BM and siLP, indicating that parabiosis resulted in adequate blood sharing (Figures 2A, B) . In contrast, the IgA + plasma cells in both the BM and siLP were <20% donor-derived, indicating that they were not in constant recirculation like their naïve B cell counterparts. The IgG + BM plasma cell pool was found to be <10% donor derived. The difference between the frequency of donor-derived IgA and IgG plasma cells may be due to a real difference in recirculation or alternatively a reflection of a higher frequency of new IgA + plasma cell generation following surgery and prophylactic antibiotic treatment. Therefore, we sought to support these findings by utilizing additional methods, including an approach wherein cells located in BM sinusoids are labeled two minutes following intravenous (i.v.) injection with PE-labeled antibodies (38) . Confirming their parenchymal residency, BM IgA + plasma cells were not labeled by this approach, whereas immature splenic and BM B cells (IgM + IgD -) and splenic plasma cells were readily labeled following i.v. injection with anti-CD19 or anti-CD138, respectively ( Figures 2C-E) . Additionally, recent work suggests that BM plasma cells preferentially localize in perivascular regions in close proximity to HSCs and regulatory T cells (39) . To determine the location of IgA + relative to IgAplasma cells in the BM, we performed whole bone tissue clearing (20) to facilitate 3-dimensional confocal imaging of intact bones from B6.Blimp1 GFP transgenic mice along with antibody staining for IgA ( Figures 3A, B) . Coordinates of IgA +/plasma cells were mapped by 3-D digital reconstruction, resulting in the detection of IgA + plasma cells in perivascular regions of the BM parenchyma similar to IgAcounterparts ( Figures 3C, D) . These results suggest there is a low level of IgA + plasma cell recirculation or IgA + plasma cells are more frequently generated and deposited in the BM during homeostasis. Overall, these data suggest that IgA + plasma cells are non-transient residents of the BM and siLP tissues. Next, we sequenced productive V H D H J H -Ca rearrangements from IgA + plasma cells in the BM and siLP of individual mice (22), the clonal composition of IgA-secreting cells was notably distinct for each mouse ( Figure 4A ). However, in each of two separate experiments we observed measurable clonal overlap for siLP and BM IgA + plasma cells within each animal ( Figures 4A, B) . Furthermore, the expressed V H D H J H -Ca repertoires for BM and siLP plasma cells within each mouse were both highly enriched for clones that had undergone somatic hypermutation (SHM). Additionally, the mutation rate was similar between both tissues ( Figure 4C ), again indicative of T-cell dependent GC-associated antibody responses. In order to examine isotype-dependent and -independent gene expression in plasma cells, we performed RNA-seq on cDNA prepared from twice sorted IgM + , IgA + and IgM/A -BM plasma cells, as well as IgA + and IgA -/-(Blimp GFP+ ) siLP plasma cells. For comparison we also sorted splenic follicular-and marginal zone-B cells. Isotype specific plasma cell samples clustered strongly by isotype with IgA+ plasma cells clustering closer regardless of tissue and IgA -/-siLP plasma cells clustering closest to IgM/A -BM plasma cells ( Figure S2A ). To validate our double sorting method, we verified that marker genes of common contaminating cells were not expressed in our plasma cell groups ( Figure S2B) . We then determined an isotypeindependent plasma cell signature by identifying all genes upregulated at least 3-fold over the B cell populations in all plasma cell subsets, yielding a total of 308 genes ( Figure S2C ). Comparing our results to the plasma cell signature published in Shi et al. (40) revealed several differences that are likely the result of varying frequencies of IgA plasma cells resulting from likely microbiome differences between facilities (7) and our use of both marginal zone (41) and follicular B cells instead of follicular B cells alone to develop our plasma cell signature ( Figure S2C) . Functional enrichment analysis of these genes showed more than half of the enriched GO terms to be related to ER function ( Figure S2D) . Given how the composition of isotypes varied the expression of non-immunoglobulin plasma cell signature genes, we sought to analyze isotype-specific gene expression between all plasma cell subsets, without respect to immunoglobulin itself. We identified 1757 genes significantly differentially expressed between all plasma cell subsets. Hierarchical clustering of these genes showed that there was a strong association between the IgA + plasma cells in the BM and siLP, with genes coregulated in these samples being enriched for cytoplasmic heat shock proteins and cholesterol homeostasis (Figures S2C, E-G) . To better determine isotype specific gene expression, we prepared contrast matrices to determine genes differentially upregulated in each isotype versus all other isotypes with IgA-specific gene expression being defined as genes upregulated in either BM or siLP IgA + plasma cells over IgM + and IgG + plasma cells ( Figure 5A ). IgM + plasma cell genes were functionally related to B cell activation and BCR signaling ( Figures 5A-C) . IgGspecific genes were few but included the IL-7 receptor (Il7ra) and Cxcr3 ( Figures 5A, D) , consistent with the association of T-bet/ Cxcr3 expression with IgG2c (42). IgA-specific genes were the largest group and included genes functionally related to heat shock, negative regulation of signaling, and a large group of histone genes associated with SLE ( Figures 5A, E, F) (43) . Interestingly there were genes related to cell positioning that were shared between the siLP and BM IgA + samples as compared with other BM plasma cell isotypes, such as higher expression of Ccr9 and Ccr10 and lower expression of surface CXCR4 which was confirmed by flow cytometry (Figures 5F, S3A) . These results indicate that BM IgA + plasma cells use a different program to home to the BM than other isotypes. Further characterization of these cells by flow cytometry revealed that BM IgA + plasma cells were negative for the gut homing chemokine receptor CCR9, despite having high levels of RNA transcripts and surface expression of the integrin heterodimer a 4 b 7 ( Figure S3A ). To further examine IgA + plasma cell gene expression as it relates to tissue, we identified genes that were up or down regulated in common between the siLP and BM samples ( Figures S3B, C) . Upregulated genes were enriched for functions associated with intestinal IgA production, while downregulated genes were enriched for inflammatory mediator functions. We then sought to determine what tissue-driven gene expression differences exist between the siLP and BM PC compartments. To isolate the effect of location in the siLP from IgA expression, we compared the plasma cell samples described above with siLP plasma cells from IgA -/mice. The isotypes present in siLP plasma cells of the IgA -/mice consisted primarily of IgG2b (61%), IgG1 (23.5%), and IgM (12%) ( Figure S3D ). Genes downregulated specifically in siLP samples included those required for emigration from secondary lymphoid structures, such as S1pr1, and genes that modulate lymphoid activation, such as the gene encoding CD30 (Tnfrsf8) ( Figure 6A ). Genes upregulated in siLP samples were enriched for functions important in protein processing in the cytosol such as the HSP70 family members Hspa1a and Hspa1b, negative regulation of map kinase signaling such as Dusp4 and Dusp8, and several inhibitory markers often associated with T cell exhaustion and tissue residency, such as Ctla4, PD-L1 (Cd274) and CD69 (Figures 6A, B) . We then examined correlation of the activation marker CD69 and several activation-induced inhibitory modulators to infer environmental cues affecting gene expression in siLP plasma cells ( Figure 6C) . We observed strong correlation between CD69 expression and both Nur-77 (Nr4a1) and Dusp4 in siLP samples. We additionally observed correlation between expression of CD69 and the related transcriptional repressors Tox and Tox2 in siLP samples ( Figure 6C) . Given that heat shock protein family genes were among the most upregulated genes in siLP plasma cell samples, we prepared a shortlist of genes containing both canonical ERlocated UPR-associated genes and cytoplasmic heat shock protein genes implicated in antigen processing, and allowed all samples to cluster freely based on the expression of these genes. This approach yielded three groups with no respect to isotype but instead samples grouped strongly into B cells, BM plasma cell samples and siLP plasma cell samples ( Figures 6D, E) . This result indicated that cytoplasmic heatshock (HSP40, HSP70) family member gene expression was tissue-restricted to siLP plasma cells and is not carried over into BM IgA + plasma cells, while as expected ERassociated HSPs were common to all plasma cell groups. Finally, we sought to determine if siLP plasma cells displayed a tissue residency phenotype. We prepared a list of genes including markers of tissue residency, secondary lymphoid (central) homing and several negative regulators of activation or exhaustion markers. These genes grouped the siLP samples closest together, with siLP samples expressing many of the residency program genes and exhaustion genes ( Figures 6F, G) . Interestingly, these genes also segregated BM plasma cells by isotype with IgA + BM plasma cells being more closely related to siLP plasma cells by expression of these genes indicating that these gene expression programs may be more closely tied to the IgA isotype. Our work demonstrates that IgA + plasma cells are long-lived residents of both the BM and siLP. This contrasts with the traditional view of siLP plasma cells as short-lived, largely Tindependent effectors that are generally restricted to mucosal tissues. We show that IgA + plasma cells in the siLP and BM are related both clonally and transcriptionally. These cells have been previously shown to be, at least in part, induced by and specific to commensal bacteria. Thus, providing an IgA + plasma cell reservoir for long-term protection from barrier disruption or transient changes in gut microbiome. In spite of the high degree of similarity between IgA + plasma cells in the siLP and BM, we were able to identify a tissue specific transcriptional gene expression pattern in siLP plasma cells with hallmarks of tissue resident T cells and uniquely high expression of cytoplasmic heat shock proteins. Therefore, while the expression of particular Ig heavy chain isotypes correlates with distinct gene expression signatures (15) , plasma cell gene expression is also influenced by tissue localization, independent of heavy chain expression. The role of long-and short-lived IgA + plasma cells in the siLP is generally believed to be the maintenance of homeostasis and to respond to changing components of the microbiome. However, the need for long-lived IgA + plasma cells in systemic sites such as the BM has not been fully explored, and it has only been recently described that long-lived IgA + plasma cells can be induced in the BM in the context of immunization. Using carbon dating Landsverk et al. described IgA + plasma cells within human gut tissue that appeared to persist for decades (3), but without single cell analyses it remained unclear whether longevity is a common feature for gut-resident plasma cells. Our data demonstrate that the vast majority of IgA + plasma cells are long-lived regardless of the tissue of residence. However, while BrdU labeling reveals that the majority of IgA + plasma cells are long-lived, we also observe that roughly 20% of the population is rapidly labeled and that population size remains stable. These data suggest that at least a portion of the IgA + plasma cells in both the bone marrow and siLP are indeed turning over frequently. Beyond that, we find that while BM and siLP IgA + plasma cells are clonally related, despite the absence of routine migration of cells to and from the gut and BM. Furthermore, despite expression of different chemokine receptors and integrins, the IgA + plasma cells in the BM occupy similar niches compared to IgG + and IgM + plasma cells. If IgA + plasma cells are capable of providing long-lived protection, then their induction is potentially of use in vaccine strategies or in the context of probiotics. The unique functional ability of IgA to act in an antiinflammatory manner could prove beneficial in some contexts and undesirable in others. Recent work has demonstrated unique roles of IgA + plasma cells in the siLP and other contexts such as multiple sclerosis. The implications of the work demonstrated here are that IgA + plasma cells can have long-term impacts on health in a variety of contexts. Interestingly, the IgA + plasma cells in the BM expressed low levels of CXCR4 on their surface and had low mRNA expression. Studies in CXCR4 -/animals have demonstrated dramatic reductions in BM plasma cell frequencies and no other known chemokine receptors have been implicated in plasma cell BM homing. Our findings suggest an alternative mechanism for IgA + plasma cell migration to the BM. Furthermore, IgA + plasma cells in the BM retain mRNA expression of gut associated chemokine receptors CCR9 and CCR10, as well as the mucosal retention integrin a 4 b 7 . The exact mechanism used by IgA + plasma cell for BM transit is still under investigation and our findings point to gene expression differences in S 1 PR 1 and integrin a 5 as potential players. However, transcriptomics only paints a partial picture and this is highlighted by high Ccr9 transcripts in bone marrow IgA + plasma cells, but low CCR9 surface protein levels as demonstrated by flow cytometry. Intriguing findings associating siLP IgA + plasma cells with canonical tissue residency gene expression profiles defined from work with T cell subsets are also targets of further expansion of this line of experimentation. Heterogeneity of plasma cell gene expression based on isotype has been previously described by Price et al. Our work expands on their findings in several ways, first by examining steady state bone marrow isotype specific plasma cells, and importantly, by the addition of IgA + plasma cells from the siLP providing us the ability to identify tissue-specific gene expression patterns. Additionally, we demonstrate that sorting plasma cells by isotype can be performed without the need of fixation and permeabilization. This opens the door to further functional studies of plasma cells based on isotype. Our RNA-seq dataset has slight variations from Price et al. that may be related to the methodology used. The work herein was not performed in an antigen specific manner, but surface staining of plasma cells using antigen-specific probes without the need for fixation/ permeabilization is also possible. Past work from our laboratory suggests that isotype is a much larger source of plasma cell heterogeneity than found comparing long-or short-lived plasma cell irrespective of isotype. It is unclear if sorting BM plasma cells by isotype and B220 expression would result in the identification of significant functional differences based on longevity and isotype combined. This work reiterates that isotype-driven transcriptional programs play a key role in plasma cell migration and function. Our data expand on this by demonstrating tissuespecific plasma cell gene transcription that has implications for strategies to induce systemic IgA. Additionally, the long-lived nature of IgA + plasma cells in the siLP and BM suggest that induction of IgA could be advantageous for durable immunity. The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: NCBI: PRJNA783313 and GSE189410. The animal study was reviewed and approved by Office of Regulatory Affairs Institutional Animal Care and Use Committee. Written informed consent was obtained from the owners for the participation of their animals in this study. JW, BG, and DA designed experiments and wrote the manuscript. BG performed RNA-seq bioinformatics analyses. JW, BG, DA, RR, and SR performed experiments. WM, AR, and EL executed the sequencing and bioinformatics analysis of antibody repertoires. All authors contributed to the article and approved the submitted version. This work was supported by National Institutes of Health (NIH) grants R01-AI139123 and R01-AI154932 to DA and F32-AI114089 to JW. EL was supported by NIH grant P30-CA016520, BG by NIH training grant T32CA009140, and RR by NIH training grant T32-AI055428. Duration of Humoral Immunity to Common Viral and Vaccine Antigens Long-Lived Bone Marrow Plasma Cells Are Induced Early in Response to T Cell-Independent or T Cell-Dependent Antigens Antibody-Secreting Plasma Cells Persist for Decades in Human Intestine Humoral Immunity Due to Long-Lived Plasma Cells Here, There, and Anywhere? Arguments for and Against the Physical Plasma Cell Survival Niche IgA Function in Relation to the Intestinal Microbiota Commensal Microbes Induce Serum IgA Responses That Protect Against Polymicrobial Sepsis Gut Microbiota-Induced Immunoglobulin G Controls Systemic Infection by Symbiotic Bacteria and Pathogens A Splenic IgM Memory Subset With Antibacterial Specificities Is Sustained From Persistent Mucosal Responses Chemokine Receptor CCR9 Contributes to the Localization of Plasma Cells to the Small Intestine Differential Expression of Tissue-Specific Adhesion Molecules on Human Circulating Antibody-Forming Cells After Systemic, Enteric, and Nasal Immunizations. A Molecular Basis for the Compartmentalization of Effector B Cell Responses Plasma Cells, the Next Generation: Beyond Antibody Secretion Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10 Acquisition of a Multifunctional IgA+ Plasma Cell Phenotype in the Gut IgM, IgG, and IgA Influenza-Specific Plasma Cells Express Divergent Transcriptomes A Functional BCR in Human IgA and IgM Plasma Cells Expression Targeted Deletion of the IgA Constant Region in Mice Leads to IgA Deficiency With Alterations in Expression of Other Ig Isotypes Protocol for Improved Resolution of Plasma Cell Subpopulations by Flow Cytometry Deep Imaging of Bone Marrow Shows Non-Dividing Stem Cells Are Mainly Perisinusoidal Parabiosis in Mice: A Detailed Protocol Diversification of Memory B Cells Drives the Continuous Adaptation of Secretory Antibodies to Gut Microbiota A Toolkit for Processing High-Throughput Sequencing Raw Reads of Lymphocyte Receptor Repertoires Comprehensive Mapping of Immune Perturbations Associated With Severe COVID-19 IgBLAST: An Immunoglobulin Variable Domain Sequence Analysis Tool ImmuneDB, a Novel Tool for the Analysis, Storage, and Dissemination of Immune Repertoire Sequencing Data Near-Optimal Probabilistic RNA-Seq Quantification Voom: Precision Weights Unlock Linear Model Analysis Tools for RNA-Seq Read Counts Limma Powers Differential Expression Analyses for RNA-Sequencing and Microarray Studies A Cytoscape Plug-in to Decipher Functionally Grouped Gene Ontology and Pathway Annotation Networks A Systematic Review of Antibody Mediated Immunity to Coronaviruses: Kinetics, Correlates of Protection, and Association With Severity Bioinformatics Enrichment Tools: Paths Toward the Comprehensive Functional Analysis of Large Gene Lists The Habitat, Double Life, Citizenship, and Forgetfulness of IgA Long-Lived Plasma Cells Are Generated in Mucosal Immune Responses and Contribute to the Bone Marrow Plasma Cell Pool in Mice Mature IgM-Expressing Plasma Cells Sense Antigen and Develop Competence for Cytokine Production Upon Antigenic Challenge Lasting Antibody Responses Are Mediated by a Combination of Newly Formed and Established Bone Marrow Plasma Cells Drawn From Clonally Distinct Precursors IgA Responses to Microbiota Cannabinoid Receptor 2 Mediates the Retention of Immature B Cells in Bone Marrow Sinusoids T Regulatory Cells Support Plasma Cell Populations in the Bone Marrow Transcriptional Profiling of Mouse B Cell Terminal Differentiation Defines a Signature for Antibody-Secreting Plasma Cells mTORC1 Coordinates an Immediate Unfolded Protein Response-Related Transcriptome in Activated B Cells Preceding Antibody Secretion T-Bet Regulates IgG Class Switching and Pathogenic Autoantibody Production Systemic Lupus Erythematosus We would like thank the UPenn Flow Cytometry and Cell Sorting facility, as well as the PennVet Center for Host-Microbial Interactions, UPenn Human Immunology Core, and all members of the PennCHOP Microbiome Program. The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fimmu.2021.791095/ full#supplementary-material Conflict of Interest: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.Publisher's Note: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.Copyright © 2021 Wilmore, Gaudette, Goḿez Atria, Rosenthal, Reiser, Meng, Rosenfeld, Luning Prak and Allman. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.